What Researchers Did
Researchers investigated the feasibility, safety, and response of administering hyperbaric oxygen (HBO) prior to stereotactic radiosurgery (SRS) for brain metastases in 38 patients.
What They Found
The average time from HBO to SRS was 8.3 minutes, and solicited adverse events were comparable between HBO and control groups, with no grade III or IV serious events. While Kaplan-Meier analysis showed no significant differences, 1-year estimated survival rates trended favorably for SRS+HBO, including radionecrosis-free survival (83% vs 60%) and overall survival (73% vs 56%).
What This Means for Canadian Patients
This approach could potentially enhance the effectiveness of stereotactic radiosurgery for Canadian patients with brain metastases by increasing tumor radiosensitivity. However, further robust clinical trials are needed to confirm these promising trends and establish definitive treatment guidelines.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The study's primary limitation is its small sample size and proof-of-principle design, which limited the ability to detect statistically significant differences in outcomes.